1. Pink Sheet
  2. >>Geography
  3. >>International

New ePortal To Simplify Processing & Tracking Of WHO Prequalification Applications

 
• By Neena Brizmohun

The World Health Organization, whose prequalification team received over 1,000 applications last year, is launching an electronic portal that should make it easier for manufacturers and regulators to keep track of submissions.

Users of the portal will be able to see where their applications sit within a specific prequalification process • Source: Shutterstock

The World Health Organization is planning to launch an electronic prequalification (PQ) system (ePQS) portal that will allow regulators and pharma and medtech companies to track prequalification products, applications and inspections more efficiently and in real time.

The new portal, which is due to go live on 1 January 2024, will be used to process PQ information...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

Quotable: Top Experts On Policy Hot Topics

 
• By Anabel Costa-Ferreira

The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.

Canada, Britain And Australia Push For Greater International Regulatory Alignment

 
• By Eliza Slawther

Canada’s drug regulator is using amended drug laws to increase the use of regulatory reliance pathways to improve efficiency and support international alignment, while the UK’s MHRA has held talks with Australia’s TGA on topics including the role of AI in regulatory frameworks.

ICH’s M14 Guideline Sets Global Standard For Non-Interventional RWD Studies

 
• By Vibha Sharma

A new guideline finalized by the International Council of Harmonisation is expected to reshape how non-interventional drug safety studies use real-world data, bringing clarity, consistency, and global alignment.

WHO Adds GLP-1s To Essential Drugs List For Informing Global Procurement And Funding

 
• By Eliza Slawther

The World Health Organization’s updated essential medicines list includes four GLP-1 drugs for the treatment of type 2 diabetes or obesity. The list is used by more than 150 companies to inform drug procurement, supply and reimbursement.

More from Geography

ACIP Weakened COVID-19 Vaccine Advice, But Less Than Rhetoric May Suggest

 
• By Sarah Karlin-Smith

The new recommendations should not change insurance coverage, but the tone of the meeting frustrated many medical experts, because of the negative comments on the vaccines.

Inexperience And Confusion: ACIP Struggles To End MMRV, Hep B Debates

 
• By Bridget Silverman

Confusion, inconsistency and strongly held views complicated the CDC's Advisory Committee on Immunization Practices' votes to change vaccine recommendations for the measles, mumps, rubella, varicella vaccine in young children and tabling of a vote on hepatitis B vaccine at birth.

US FDA Appears To Be Managing MAHA Well By Feeding Instead Of Receiving Priorities

 
• By Ramsey Baghdadi

The newly issued Make America Healthy Again strategy report suggests that FDA leaders are doing a good job of feeding ideas to the Trump Administration, rather than having the agency agenda dictated from above.